NEWS BRIEF

Digital solutions today
Clinicians face growing pressures from rising patient volumes, staffing shortages, and complex procedures. GE HealthCare’s MIM Software offers comprehensive vendor-agnostic solutions that aim to support fast, accurate diagnostics and streamlined workflows to help boost efficiency and precision care. MIM Encore, MIM SurePlan MRT, and MIM LesionID Pro together offer intuitive image processing, AI-based segmentation, tumor burden quantitation, practical dosimetry, and workflow automation. The single MIM platform supports molecular imaging across care areas, including oncology, cardiology, and neurology — with tools that help streamline manual tasks and aim to enhance diagnostic confidence. As healthcare shifts toward personalized care, these solutions empower clinicians to help improve patient outcomes through efficient, scalable and connected digital tools that integrate easily into clinical workflows.

MIM LesionID Pro™ with automated zero-click pre-processingi
MIM LesionID Proi with automated zero-click pre-processing is designed to offer an innovative solution that aims to transform whole-body tumor burden analysis. This AI-powered solution is designed to provide a zero-click pre-processing experience that aims to streamline the extraction of quantitative biomarkers from patient imaging, helping make precision oncology a practical reality.

Designed for nuclear medicine physicians and oncologists treating metastatic castration-resistant prostate cancer (mCRPC), MIM LesionID Pro provides automated total tumor burden (TTB) statistics, including total tumor volume (TTV), SUV mean, and SUV max on PSMA PET/CT and SPECT/CT scans. Designed with enhanced algorithms and intuitive automation, the platform aims to aid clinicians in making treatment decisions, confidently monitoring treatment response, and guiding downstream decisions with robust quantitative insights. MIM LesionID Pro is a powerful example of how AI can help elevate clinical decision-making in prostate cancer care.

MIM Encore™
MIM Encore is GE HealthCare’s next-generation digital imaging and workflow platform designed to help advance precision care. Now powered with additional GE HealthCare features and algorithms, MIM Encore delivers an integrated reporting experience for PET, SPECT imaging. It combines automation, multi-modality support, and advanced visualization tools to streamline workflows across molecular imaging and the care areas it supports. Its vendor-agnostic design enables interoperability across systems, while seamless automation helps accelerate image processing, reporting and communication with referrers. MIM Encore empowers clinicians to make confident, timely decisions and deliver personalized treatment plans—helping meet the demands of today’s fast-paced, data-driven healthcare environments.

Media contact
Kelsey Stanczyk
Communications Manager
Molecular Imaging and Computed Tomography – MIM Software
Kelsey.stanczyk@gehealthcare.com
M: +1 262-450-0982

iLesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region.

JB35933XX